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A B S T R A C T
Background: The temporal dynamics of cortisol may be altered in depression. Optimally studying these dynamics
in daily life requires specific analytical methods. We used a continuous-time multilevel process model to study
set point (rhythm-corrected mean), variability around this set point, and regulation strength (speed with which
cortisol levels regulate back to the set point after any perturbation). We examined the generalizability of the
parameters across two data sets with different sampling and assay methods, and the hypothesis that regulation
strength, but not set point or variability thereof, would be altered in depressed, compared to non-depressed
individuals.
Methods: The first data set is a general population sample of female twins (n = 523), of which 21 were de-
pressed, with saliva samples collected 10 times a day for 5 days. The second data set consists of pair-matched
clinically depressed and non-depressed individuals (n = 30), who collected saliva samples 3 times a day for 30
days. Set point, regulation strength and variability were examined using a Bayesian multilevel Ornstein-
Uhlenbeck (OU) process model. They were first compared between samples, and thereafter assessed within
samples in relation to depression.
Results: Set point and variability of salivary cortisol were twice as high in the female twin sample, compared to
the pair-matched sample. The ratio between set point and variability, as well as regulation strength, which are
relative measures and therefore less affected by the specific assay method, were similar across samples. The
average regulation strength was high; after an increase in cortisol, cortisol levels would decrease by 63 % after
10 min, and by 95 % after 30 min, but depressed individuals of the pair-matched sample displayed an even faster
regulation strength.
Conclusions: The OU process model recovered similar cortisol dynamics for the relative parameters of the two
data sets. The results suggest that regulation strength is increased in depressed individuals. We recommend the
presented methodology for future studies and call for replications with more diverse depressed populations.
1. Introduction
Depression is a prevalent stress-related disorder, with an often re-
current or chronic course (Moussavi et al., 2007). Research into the
pathophysiology of depression has often focused on cortisol levels, as
cortisol is the end-product of the hypothalamic-pituitary-adrenal (HPA)
axis, one of the major stress systems in the body. Findings to date re-
garding the association between basal cortisol levels and depression in
large cross-sectional as well as in-depth repeated assessment studies
have been inconclusive (Booij et al., 2015; Stetler and Miller, 2011).
Part of these mixed results may be explained by the high fluctuation of
cortisol levels. Thus, examining the way cortisol behaves over time (i.e.
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its temporal dynamics rather than just basal levels alone) within de-
pressed and non-depressed individuals may help us better understand
the underlying mechanisms of depression.
Cortisol is one of the important mediators of allostasis, the dynamic
process that keeps the organism alive by “maintaining stability through
change”, and promoting adaptation and coping (McEwen, 2002). Al-
lostasis includes circadian (daily) and ultradian (hourly) rhythms; the
latter are thought to optimize HPA axis responsiveness to the en-
vironment and to be important for normal cognitive, emotional and
metabolic functioning (Gjerstad et al., 2018). Laboratory studies in
depressed individuals have shown that several aspects of ultradian
dynamics are altered, such as changes in the duration, amplitude and
frequency of pulsatile episodes (Deuschle et al., 1997; Halbreich et al.,
1985; Linkowski et al., 1985; Mortola et al., 1987). Additionally, ex-
perimentally-induced changes in ultradian dynamics of cortisol in the
brain influence emotional and cognitive processes that have also been
shown to be affected in mood disorders (Harmer et al., 2017;
Kalafatakis et al., 2018).
A study by Peeters et al. (2004) was the first to examine depressed
and non-depressed individuals’ moment-to-moment cortisol dynamics
in the participants’ natural environment, representing an ecologically
valid setting. They found that subsequently assessed cortisol samples
(with 90-minute intervals on average) were less strongly associated
over time (i.e. lower autocorrelation) in depressed than in non-de-
pressed individuals, especially in those with more severe or recurrent
episodes. They found no differences in mean (set point) or variability of
cortisol levels. While the findings regarding autocorrelation point to
alterations in cortisol regulation, the magnitude and direction (in-
creased or decreased) of the malfunctioning remains unclear. One ex-
planation for this is that this study did not consider the dynamic
characteristics together from a context that captures cortisol regulation
as a dynamical process.
Within-individual psychobiological processes such as cortisol reg-
ulation are mostly analyzed using discrete-time approaches, such as
(multilevel) autoregressive models (van Ockenburg et al., 2015).
However, such models do not consider how phenomena change con-
tinuously over time, between observations. Only under strict circum-
stances, such as equally spaced sampling intervals and normally dis-
tributed data (e.g. Ryan et al., 2018), can a discrete time model give a
reasonable approximation to continuous time processes. However, in
practice these assumptions are hardly ever met. Discrete time models
also make it impossible to compare studies that have different sampling
intervals (Voelkle and Oud, 2013). In addition, these models are most
often fitted to data in multiple steps (as opposed to one-step), this way
generating bias in the estimation (Pagan, 1984): point estimates of
model parameters are regressed on predictors, without considering the
error in the parameter estimates.
In the current study, we argue that a state-of-the-art continuous-
time stochastic differential modeling approach, namely the multilevel/
hierarchical Ornstein-Uhlenbeck (OU) process model (Oravecz et al.,
2009, 2016) can address the above-mentioned issues. This model was
originally developed for capturing affect dynamics (Kuppens et al.,
2010), but can also be applied to other dynamic processes with set
points. With this approach, short-term within-individual changes in
cortisol are described using stochastic differential equations based on
the OU process (Uhlenbeck and Ornstein, 1930). The OU process is a
continuous-time model defined by a stochastic differential equation
with three parameters: set-point, regulation towards the set-point, and
stochastic variation around the set-point. Because of its continuous-time
nature, it also conforms with the properties of unequally spaced, un-
structured and unbalanced experience sampling data, this way pro-
viding pertinent insights into continuous-time cortisol regulation, in-
dependent of the specific measurement choices. Its parameter capturing
regulation strength indicates how quickly cortisol levels regulate back
towards the set point after any perturbation. Since this parameter
comes from a continuous time model, the sampling frequencies do not
scale its value, therefore we can compare regulation strength across
studies. Finally, the estimated process model parameters can be mapped
directly to the theorized behavioral characteristics of cortisol: set points,
regulation and stochastic perturbations, resulting in within-person
variability in cortisol.
The individual level process model is cast in a Bayesian multilevel
framework (Gelman et al., 2013) that accommodates simultaneous
modeling of multiple individuals. With this approach we derive in-
dividual and group level parameters at once, with the estimates in-
forming each other. Moreover, the multilevel Bayesian framework al-
lows us to introduce predictors on the process model parameters (i.e.,
on set-points, within-person variabilities and regulations strengths) and
estimate the corresponding regression coefficients, process model
parameters, and group-level characteristics simultaneously – this is a
one-step approach to estimation that is only feasible in the Bayesian
framework for the OU model (Oravecz et al., 2016).
With the current study, we aimed to examine set point, regulation
strength and variability of cortisol by fitting the OU process model to
cortisol time-series data of depressed and non-depressed individuals
from two different samples. Because the OU model was applied to
salivary cortisol data for the first time, we started with comparing set
points, regulation strengths and variabilities of cortisol across the two
samples to examine whether these parameters largely align. Second, we
examined whether individual differences in these parameters are re-
lated to (recurrent) depression. In accordance with the study of Peeters
et al. (2004), we hypothesized that individuals with depression, espe-
cially those with chronic/recurrent depression, have altered (be it in-
creased or decreased) regulation strength compared to individuals
without chronic/recurrent depressive episodes, but similar set points
and variability.
2. Methods
2.1. Sample and procedures
We tested our hypotheses using data from two ecological momen-
tary assessment (EMA) studies. In an EMA study participants complete
assessments during their daily lives, this way facilitating ecological
validity of those measures; for more information about this metho-
dology, see Stone and Shiffman (1994). The first sample comprised
females (mostly twins, therefore referred to as ‘female twin sample’)
from the general population (Flanders, Belgium), who sampled saliva
ten times a day for five days (Jacobs et al., 2007). The second sample
consisted of depressed and pair-matched non-depressed individuals of
both genders (therefore referred to as ‘pair-matched sample’), who
sampled saliva three times a day for thirty days (Booij et al., 2015).
2.1.1. Female twin sample
2.1.1.1. Participants. The sample comprised 621 women (577 twins
and 44 non-twin sisters) aged 18–61 years (mean 28 years). Participants
were recruited from the East-Flanders Prospective Twin Survey (EFPTS)
(Derom et al., 2013; Loos et al., 1998) and from birth registers of
Flemish municipalities. The EFPTS is a population-based survey that
started in 1964, registering prospectively all multiple births within East
Flanders. The project was approved by the local medical ethics
committee and all participants gave their written consent.
Of the 621 women, 610 participated in the ambulatory assessment
procedure. We excluded 80 participants who did not have at least 25
(50 %) valid salivary cortisol samples, to ensure enough observations
for fitting the continuous time model to the data. In line with a previous
study, participants with more than 20 % of cortisol values above
44 nmol/L were also excluded (n = 4) (Jacobs et al., 2007). In addition,
extreme values (> = 100 nmol/L) were set to missing. As a result, one
more participant was excluded due to insufficient valid salivary cortisol
samples. Finally, two participants were excluded because of missing age
or depression diagnosis. This left 523 women for the analyses, of which
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21 were diagnosed with a depressive episode according to the Struc-
tural Clinical Interview for DSM-IV (see section 2.2.2 for more details).
2.1.1.2. Ambulatory sampling procedures. Subjects received a digital
wristwatch that emitted a signal ten times a day on five consecutive
days, at random times between 7:30 a.m. and 10:30 p.m. After each
‘beep’, subjects completed self-assessment forms concerning current
context, thoughts, and emotions. For a schematic representation of the
sampling scheme, please see Fig. 1. After completion, subjects were
asked to take a saliva sample (Salivette, Sarstedt, EttenLeur,
Netherlands). After saliva collection, the subjects were instructed to
store the swab in a salivette tube and to record the exact time of
collection on the label. Samples were stored in the subjects’ home
freezers until transport to the lab, where uncentrifuged samples were
kept at −20 °C until analyses. To know whether the subjects had
performed their tasks (filling in the form and taking the saliva sample)
within 15 min of the beep, the self-indicated time of sample collection
was compared with the actual time of the beep (Jacobs et al., 2005). All
data not collected within 15 min after the beep were excluded from the
analysis (as these were already excluded from the current dataset, they
did not further affect the current sample size). Salivary free cortisol
levels were determined in duplicate, using a time-resolved
immunoassay with fluorescence detection. The lower detection limit
of this assay was 0.2 nmol/L; interassay and intraassay coefficients of
variation were less than 10 %. For more information regarding the
sampling procedure and the determination of cortisol levels from the
saliva samples, please see Jacobs et al. (2007).
2.1.2. Pair-matched sample
2.1.2.1. Participants. The sample was part of the ‘Mood and movement
in daily life’ study, in which depressed and non-depressed participants
(aged 20–50 years; mean age: 34 years) were ambulatory monitored
three times a day for 30 days by means of electronic diaries, actigraphy,
and saliva sampling. This resulted in a maximum number of 90 salivary
cortisol samples per individual. Participants with and without a
depressive disorder were pair-matched on gender, smoking, age, and
BMI (see Booij et al. (2015) for further details on the matching
procedure).
Before inclusion, participants were screened for depressive symp-
tomatology with the Beck Depression Inventory (BDI-II, Beck et al.,
1996), which was followed by a Composite International Diagnostic
Interview (CIDI) (World Health Organization, 1990) if they had a BDI
score > 14 (depressed group) or < 9 (non-depressed group). Depressed
individuals were included if they met criteria for a DSM-IV diagnosis of
Major Depressive Disorder (MDD; current episode or in remission for no
longer than 8 weeks). Non-depressed individuals were included if were
free of mood disorders at the moment of inclusion. Individuals with a
current or recent (within the last two years) psychotic or bipolar dis-
order were excluded. Other reasons for exclusion were pregnancy and
significant hearing or visual impairments. The study design was ap-
proved by the responsible Medical Ethical Committee, and all partici-
pants gave written consent before inclusion.
Of the 62 participants who started the study, 4 participants dropped
out early. Another 4 participants completed the study but did not have
enough valid measurements (T < 60) due to non-compliance, tech-
nical problems, or protocol violations. This left 54 participants for
further study. The present study was based on the subsample for which
cortisol and α-amylase concentrations have been determined, con-
sisting of 15 matched pairs (n = 30, whereof 15 depressed and 15 non-
depressed individuals). They did not differ significantly from the re-
maining participants on BDI score, gender, age, BMI and smoking status
(p > 0.05). We discarded two-thirds of the data of one participant
(D12), who reported a breast infection during this period and had re-
latively high values in this period (mean = 19.7 nmol/l). Values re-
turned to a more normal range after day 20, around when she had
started taking antibiotics. Therefore, we included data from the last 10
days (t = 30) only for this participant. The dataset is available online
(doi: 10.1371/journal.pone.0131002).
2.1.2.2. Ambulatory sampling procedures. The participants completed
questionnaires on an electronic diary, the PsyMate® (PsyMate BV,
Maastricht, The Netherlands) (Myin-Germeys et al., 2011) for a total
of 32 days, of which the first two days served to get familiar with the
device. The electronic diary questionnaire contained 60 items on mood,
cognition, and daily activities and habits. The PsyMate was
programmed to generate beeps at three predetermined moments a
day at equidistant time points: in the morning (mean≈10 AM), six
hours later in the afternoon (mean≈4 PM) and again six hours later in
the evening (mean≈10 PM). The exact time points depended on
participants’ sleep-wake schedule. Participants were instructed to fill
Fig. 1. Graphical representation of sampling schemes of the female twin sample (upper part) and pair-matched sample (lower part).
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out the diary immediately after the beep, but a delay of maximally 1 h
was allowed. For a schematic representation of the sampling scheme,
please see Fig. 1. Saliva was collected while completing the diary, by
means of a synthetic salivette collection device. More information about
the sampling and storage procedures can be found in Booij et al. (2015).
Salivary cortisol samples were analyzed by means of online-solid phase
extraction in combination with isotope dilution liquid chromatography-
tandem mass spectrometry (LC–MS/MS), which has a broad analyte
compatibility and high analytical performance. All samples of one
participant were assayed in the same batch. Mean intra- and inter-assay
coefficients of variation were below 10 %. The quantification limit for
cortisol was 0.1 nmol/L.
2.2. Variables
2.2.1. Cortisol dynamics
Set point, regulation and within-person variability of salivary cor-
tisol were estimated from the data. (1) Set point (μ) represents the level
to which cortisol is regulated towards and it can change as a function of
time. For example, in humans, cortisol has a higher set point in the
morning than in the evening, due to circadian rhythmicity. Statistically,
this translates into making set point a function of time-varying pre-
dictors – in this study, time of the day was used as a time-varying
predictor. Examples of two hypothetical individuals with different set
points are presented in Fig. 2A. In these examples, the mean set point is
corrected already for time of day, to account for different set points at
different phases of the circadian rhythm. Person (P)1 has a relatively
high set point (μ = 7), while P2 has a relatively low set point (μ = 2).
(2) Regulation strength (β) captures how quickly cortisol levels regulate
back towards the set point after any perturbation; increased regulation
strength relates directly and inversely to the continuous-time auto-
correlation function. To illustrate what regulation strength is, two hy-
pothetical individuals with different regulation strength are presented
in Fig. 2B. For person (P)1, cortisol levels return quickly after a per-
turbation to the system, indicating strong regulation (P1; β = 6), while
for person (P)2, cortisol levels remain high for several hours, which
indicates weak regulation (P2; β = 0.1). (3) Within-person variability
(γ) in cortisol levels is caused by perturbations, which are external and/
or internal inputs, such as ultradian oscillations, daily hassles, caffeine
intake, and physical activity. In cross-sectional group studies, this is
usually (incorrectly) regarded as measurement error. Examples of two
hypothetical individuals who differ in variability are presented in
Fig. 2C. P1 shows relatively little variability (γ = 1), while P2 shows
relatively large variability (γ = 3).
2.2.2. Depression diagnoses
For the female twin sample, the Structured Clinical Interview for
DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4th
Edition) axis I disorders (SCID-I) was administered to obtain current
and lifetime diagnoses of MDD. For the pair-matched sample, current
and lifetimes diagnoses of MDD were obtained from the CIDI interview.
The current diagnoses were used to create groups of depressed and non-
depressed individuals.
Individuals were further classified using both the lifetime and cur-
rent diagnoses of MDD. Subjects were designated to a never depressed
(no current or past depression), acute depression (current depression,
no past depression), chronic depression (current and past depression) or
past depression (no current, but past depression) group. In the pair-
matched sample, there was only one currently healthy participant with
a past depression (> seven years ago). Because she was the only one in
this category and the depression occurred more than 7 years ago, the
analysis was conducted with her in the never depressed category.
2.2.3. Descriptive variables
Age, gender, and completed education (0=primary education, 1=
secondary education, 2=university/college education), and BMI were
based on self-report. Severity of depressive symptoms was calculated as
the average item score of the 16 items of the SCL-90 depression subscale
(Derogatis and Unger, 2010) in the female twin sample) and as the total
sum score of the 21 items of the BDI in the pair-matched sample at the
start of the study.
2.3. Statistical analysis
We fit the described multilevel OU process model to study the three
intra-individual dynamic features, namely set point, regulation strength
and variability of salivary cortisol. First, we explored the intra-in-
dividual temporal dynamics of cortisol across the two samples (model
1). Because different cortisol assay methods were used for the two
samples (radioimmunoassay versus liquid chromatography-tandem
mass spectrometry), we expected that the absolute levels and variability
might be different (Bae et al., 2016; Baecher et al., 2013). Therefore, we
also compared the ratio between the set point and variability for the
two samples as this measure is a relative measure, and might be less
influenced by the assay method and was hypothesized to be similar for
both samples. Second, we related these dynamics to individual
Fig. 2. Examples of hypothetical differences in set point (A), regulation
strength (B) and variability (C) of salivary cortisol. Red / dot dashed lines re-
present P1, whereas green / solid lines represent P2 (For interpretation of the
references to colour in this figure legend, the reader is referred to the web
version of this article).
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differences in depression (model 2). We also included gender (only in
the pair-matched sample) and age as covariates, as they have been
previously related to cortisol levels (e.g. Larsson et al., 2009; Roelfsema
et al., 2017). Finally, to confirm previous findings that cortisol dy-
namics are particularly altered in individuals with chronic/recurrent
depression, we also examined never depressed, acute, past and
chronically depressed individuals separately (model 3).
Models for cortisol were fit to the data of the two samples (pair-
matched: 5 % missing observations; female twin: 25 % missing ob-
servations). Data were inherently nested, in the sense that there were
multiple cortisol records (level 1) per person (level 2). Predictor vari-
ables were organized into time-varying covariates (time of day, time of
day squared), and time-invariant predictors (gender, age, depression).
To appropriately place the data in continuous time, a time variable was
constructed, operationalized as the number of hours of each observa-
tion since midnight of the first day of each individuals’ measurement
burst.
The dynamical model parameters of the multilevel OU process
model were estimated in the Bayesian framework, using Markov chain
Monte Carlo algorithms. The data analysis was carried out in R (R Core
Team, 2017) and JAGS (Plummer, 2003), with rjags (Plummer, 2016)
that helped running JAGS from R. Scripts can be found as supplemental
material S1. Bayesian estimation results in a posterior probability dis-
tribution for each parameter that summarizes the plausible range of the
parameter, conditional on the data and prior settings, see (Gelman
et al., 2013). In the Bayesian framework, p-values or 95 % confidence
intervals are not defined; instead we calculate the 95 % Credibility
Intervals based on the posterior probability distribution of the corre-
sponding parameter. Credibility Intervals (CI) are interpreted as fol-
lows: the parameter is within the estimated 95 % Credibility Interval
with a 95 % probability. Based on the posterior probability distribution
we can also calculate summary statistics such as the estimate’s posterior
mean (a point estimate) and posterior standard deviation (similar to the
standard error of the estimate). In this framework, we can assess
whether a regression effect is credibly different from 0 by checking
whether the regression coefficient estimate’s 95 % CI contains 0.
First, model 1 was fitted to both data sets to study cortisol dynamics
(model 1) in the two samples. The ratio between the set point and
variability was also calculated. This model had only measurement time
as a time-varying predictor to correct for the circadian rhythm. We let
the set-point vary as linear and quadratic functions of time of day,
because, with these variables together, we can model a curvilinear re-
lationship (instead of only linear) to capture the potential rise and fall
in the daily cortisol rhythm. Measurement time was centered on 12 a.m.
(midday), so that the intercept quantifies the cortisol level at noon.
Second, we fitted model 2 that also included gender (1=male, 0=fe-
male; pair-matched sample only), age (centered), and depression (de-
pressed = 1, non-depressed = 0) as predictors of inter-individual dif-
ferences in the parameters under study. Finally, we fitted model 3 with
dummy variables for current, past (female twin sample only) and
chronic depression (reference category = never depressed).
The outcome parameters and the effects of within-person predictors
(i.e. time effects) were allowed to be person-specific. They are assumed
to be sampled from a population distribution (i.e., they are random
effects), which accounts for individual differences. Measurement error
was not modeled separately from intra-individual variation. Models
were first fitted using 6 chains, taking 20.000 posterior samples per
chain after 2000 samples of discarded burn-in per chain (120.000
samples in total). An exception was model 2 for the pair-matched
sample, which was a bit slower to converge, and needed 150.000
samples, instead of 120.000. We checked whether all six chains con-
verged to the same area of the posterior distribution by calculating Rhat
statistics (Gelman et al., 2013), all of which were below 1.1, therefore
we concluded that there were no problems with convergence.
Table 1
Summary of demographic, clinical and biological variables.
Female twin (1) Pair-matched (2) Both samples
Characteristics Dep (n = 21) Non-dep
(n = 502)
Dep vs. non-dep Dep (n = 15) Non-dep
(n = 15)
Dep vs. non-dep 1 versus 2
Mean (SD) Mean (SD) Significance test Mann-
Whitney/ Chi-square






Gender, n (%) female 21 (100) 502 (100) NA 11 (73.3) 11 (73.3) NA NA
Age 29.4 (9.4) 28.0 (7.9) U = 5600, p=.63 35.9 (10.5) 35.1 (8.4) U = 123, p = .68 U = 11800, p= < .01
BMI 19.1 (3.1) 18.1 (2.8) U = 6415, p=.09 23.6 (4.5) 22.5 (2.8) U = 124, p = .65 U = 13861, p < .01
Smoking status n (%) smoking 4 (20.0) 136 (27.8) χ2 (1) = 0.37, p=.51 3 (20.0) 3 (20.0) NA χ2 (1) = 0.81, p = .37
Highest completed education n
(%)
χ2 (2) = 3.47, p = .18 χ2 (1) = 0.91,
p = .34
χ2 (2) = 5.28, p = .07
Primary education 1 (4.8) 7 (1.4) 0 0
Secondary education 10 (47.7) 171 (34.1) 64.3 46.7
University / college education 10 (47.6) 324 (64.5) 35.7 53.3
Clinical
History (n (%) with prior
episodes)
10 (47.6) 79 (15.7) χ2 (1) = 14.46,
p= < .01
10 (66.7) 1 (6.7) χ2 (1) = 11.63,
p= < .01
χ2 (1) = 7.36, p = .07
Depressive symptoms* 2.1 (0.8) 1.4 (0.5) U = 8061, p < .01 30.8 (9.8) 2.4 (3.1) U = 225, p < .01 NA
Hormonal contraceptive use
(systemic), n (% women)
9 (42.9) 267 (53.2) χ2 (1) = 0.86, p=.35 3 (27.3) 4 (36.4) χ2 (1) = 0.21,
p = .65
χ2 (1) = 3.71, p = .05
Antidepressant medication, n (%
using)***
3 (14.3) 16 (3.2) χ2 (1) = 7.09, p= < .01 5 (33.3) – χ2 (1) = 6.00,
p = .01
χ2 (1) = 11.61, p= < .01
Biological
Average salivary cortisol levels
(nmol/l)
8.5 (4.1) 7.8 (2.7) -** 3.9 (1.3) 3.5 (1.4) -** U = 1075, p < .01
Note: Smoking was missing for 13 non-depressed and 1 depressed individual of the female twin sample. Highest completed education was missing for 1 depressed
individual of the pair-matched sample.
* Depressive symptoms were assessed with the SCL-90 questionnaire (range 1–5; the total score was divided by the number of valid items) (female twin) and the
BDI questionnaire (range 1–63) (pair-matched).
** These differences have been tested with the Bayesian multilevel Ornstein Uhlenbeck model.
*** Two depressed individuals used Saint John’s wort.




3.1.1. Comparison of samples
Descriptive statistics of the depressed and non-depressed groups of
the two samples are shown in Table 1. The female twin sample was on
average 7.5 years younger, scored 4.95 points lower on BMI and had
4.1 nmol/l higher mean levels of salivary cortisol than the pair-matched
sample. In addition, the female twin sample included relatively higher
numbers of oral contraceptive users (borderline significant) and lower
numbers of antidepressant users. Smoking behavior was not sig-
nificantly different between the two samples, nor was education level
and the number of individuals with a previous depressive episode.
3.1.2. Comparison of depressed and non-depressed groups per sample
As shown in Table 1, for the female twin sample, age, BMI, smoking
status, education level and oral contraceptive use were not significantly
different between the depressed and the non-depressed group. SCL-90
depressive symptom scores were significantly higher, there were less
individuals with a previous depressive episode, and there were more
individuals using antidepressants in the depressed group. For the pair-
matched sample, gender, age, BMI, smoking status, education level and
oral contraceptive use were not significantly different between the
depressed and the non-depressed group, while the BDI depressive
symptoms score was significantly higher, the number of individuals
with a previous depressive episode and the number of individuals using
antidepressants was significantly higher in the depressed group
(Table 1).
3.2. Cortisol dynamics; basic model compared across the samples (Model 1)
Table 2 shows results from the three models specified previously in
terms of average levels of set points (rhythm-corrected mean), varia-
bility (fluctuations around the mean) and regulation strength (the speed
of return to baseline after a perturbation) of salivary cortisol across
both samples. For all three parameters point estimates (posterior
mean), error estimates (posterior SD) and interval estimates (95 % CI)
are reported.
The average set point for the female twin sample was 10.05 nmol/l
around noon, almost twice as high as for the pair-matched sample
(5.29 nmol/l), both credibly different from 0 (95 % credibility interval
non-overlapping with 0). The regulation strength was about equal in
both samples, around 1.8. This equals to a decrease of about 40 % after
5 min, 63 % after 10 min, and 95 % after 30 min (see Fig. 3, for the
complete continuous-time autocorrelation curve). The average within-
person (intra-individual variability) was about twice as large in the
female twin sample (2.77) as the pair-matched sample (1.49) as well.
The ratio between set point and variability was about the same in both
samples, around 3.6. All three parameters showed substantial inter-in-
dividual variation, as quantified as SDs in the bottom part of Table 2.
3.3. Inter-individual variation in cortisol dynamics; association to gender,
age and depression (Model 2)
The goal of model 2 was to study associations between depression
(and gender and age as covariates) and set point, variability and reg-
ulation strength, of which the results are presented in Table 2.
Set point was not credibly related to depression in either of the
samples. It was also not credibly associated to gender in the pair-mat-
ched sample. Set point was related to age in the female twin sample
only, with older individuals showing lower set-points.
Credibly increased regulation strength for cortisol was found in the
depressed group of the pair-matched sample, but not in the female twin
sample. Regulation strength was not credibly associated with gender.
Regulation strength was credibly associated with age in the female twin
sample only, indicating faster returns to the set point with increasing
age.
Variability was not credibly related to depression in the two sam-
ples. Variability of cortisol was credibly associated with gender in the
pair-matched sample, where men showed less variability than women.
Variability was credibly associated with age in the female twin sample
only, with older participants showing less variability.
3.4. Inter-individual variation in cortisol dynamics; association to acute,
chronic and past depression (Model 3)
When splitting up the two groups into acute, chronic, past and never
depressed individuals, none of these groups showed credible associa-
tions to set point or variability, which result is consistent with Model 2
(Table 2). The chronic depressed group of the pair-matched sample, but
not the female twin sample, showed credibly increased regulation
strength. The acute and past depression groups did not show credible
differences in terms of regulation strength.
4. Discussion
In the current study, we examined intra-individual cortisol dy-
namics in two different samples in ecologically valid settings, and
compared depressed and non-depressed individuals within these sam-
ples. Specifically, we examined set point, regulation strength and
variability of salivary cortisol. For this, we used a multilevel con-
tinuous-time process model appropriate for the nested, unequally-
spaced cortisol data at hand. The set point and variability were twice as
high in the female twin sample as in the pair-matched sample.
However, the ratio between these two variables, as well as the reg-
ulation strength to the set point, which are relative measures (opposed
to the absolute values of set point and variability), were very similar,
indicating generalizability across different populations. This supports
the utility of the adopted method to study cortisol dynamics in daily
life, even in different ambulatory sampling designs. Previous findings of
a study reporting lower autocorrelation in depressed compared to non-
depressed individuals (Peeters et al., 2004) were replicated and ex-
tended in one out of two samples, showing increased regulation
strength in depressed individuals.
The fact that the set point and variability were different across
samples can be due to the fact that the specific levels of salivary cortisol
are very much dependent on a variety of factors. A very important
factor is the assay method. The saliva samples of the female twin
sample were analyzed with radioimmunoassay, while the samples from
the pair-matched sample were analyzed with liquid chromatography-
tandem mass spectrometry (LC–MS/MS). Previous studies comparing
these two methods have shown that radioimmunoassay can over-
estimate cortisol levels by one-and-a-half to two-fold, compared to
LC–MS/MS (e.g. Bae et al., 2016; Baecher et al., 2013). This is mainly
due to cross-reactivity of immunometric cortisol assays with inactive
cortisone. Putting such a correction factor on the female twin sample,
results in similar parameters to the pair-matched sample. The difference
in gender composition could also contribute to the differences in set
point and variability, although this is less likely because gender is
usually weakly/not related to basal levels (Hansen et al., 2008). Im-
portantly, the ratios between the variability and the set point at noon as
well as the regulation strength were roughly the same, indicating that,
even though the absolute values of the parameters may be confounded,
relative indices were not, and may be useful cross-sample indicators of
cortisol dynamics.
The recovered parameters for regulation strength suggest that if one
would give an isolated boost of cortisol secretion at one moment, the
levels decrease to about 50 % after 10 min, and about 95 % after
30 min. With the current study, we mainly captured small fluctuations
in salivary cortisol during daily life. One of the major factors con-
tributing to within-person fluctuations is the ultradian (about hourly)
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rhythm of cortisol (Young et al., 2004). Although our results cannot be
directly compared to laboratory studies on ultradian rhythms due to
different analytical methods, the calculated autocorrelation curve fits
roughly with what is known about these bursts. Laboratory studies with
high-frequency sampling (i.e. at 10−20 minute intervals) have shown
that cortisol fluctuations come in several bursts during the day (i.e.
ultradian oscillations) (Young et al., 2004). Bursts come in hourly os-
cillations, and the burst half duration has been estimated between
16–27 minutes (Carroll et al., 2012; Veldhuis et al., 2011, 1989). Fi-
nally, it has been found that subsequent bursts are not correlated to
each other, meaning that there is no autocorrelation over > 1 h
(Veldhuis et al., 1989), which matches our findings. Hence, with re-
spect to what is known about cortisol regulation in the context of ul-
tradian rhythms, our estimates for regulation strength seem plausible.
Based on our results and prior studies (Oravecz and Tuerlinckx,
2011), the recommendation for the number of observations for studying
cortisol with the OU model is at least 50. Because of the continuous-
time nature of the model, the total number of observations is more
important than the within-day sampling frequency. In the current
study, we obtained similar results across the two samples for the
parameters that were based on relative estimates using either a high
within-day sampling frequency over five days (t = 50) or a lower
within-day sampling frequency over a month (t = 90). However, be-
cause cortisol’s diurnal pattern (in our case quadratic) needs to be
captured, the minimum within-day frequency is three. The OU model
Table 2
Results on average levels of salivary cortisol set point, within-person variability and regulation strength.
Female twin Pair-matched
Posterior mean Posterior SD 95 % CI Posterior mean Posterior SD 95 % CI
Model 1
Set point# 10.05 0.16 9.74 – 10.35* 5.29 0.32 4.67 – 5.93*
Regulation strength 1.82 0.25 1.32 – 2.20* 1.87 0.35 0.90 – 2.21*
Variability 2.77 0.04 2.68 – 2.85* 1.49 0.17 1.15 – 1.83*
SD. Set point 3.38 0.12 3.15 – 3.62* 1.68 0.25 1.27 – 2.24*
SD. Regulation strength 1.31 0.12 1.07 – 1.52* 0.50 0.40 0.05 – 1.51*
SD. Variability 0.96 0.03 0.90 – 1.02* 0.92 0.13 0.71 – 1.22*
Model 2
Set point# 10.03 0.16 9.73 – 10.34* 5.09 0.44 4.23 – 5.96*
Depression 0.32 0.79 −1.22 – 1.87 0.43 0.62 −0.81 – 1.65
Gender – – – −0.55 0.32 −1.17 – 0.07
Age −0.07 0.02 −0.11 – -0.04* −0.04 0.03 −0.10 – 0.03
Regulation strength 1.83 0.25 1.32 – 2.20* 1.53 0.55 0.18 – 2.20*
Depression −0.32 0.55 −1.32 – 0.86 8.51 6.07 0.29 – 22.74*
Gender – – – 0.65 1.13 −1.06 – 3.28
Age 0.05 0.01 0.02 – 0.09* −0.09 0.12 −0.33 – 0.12
Variability 2.76 0.04 2.67 – 2.84* 1.37 0.23 0.92 – 1.83*
Depression 0.23 0.22 −0.20 – 0.67 0.23 0.33 −0.42 – 0.88
Gender – – – −0.36 0.17 −0.69 - -0.03*
Age −0.01 0.01 −0.02 – -0.00* −0.02 0.02 −0.05 – 0.02
Model 3
Set point# 9.91 0.17 9.57 – 10.25* 5.09 0.44 4.22 – 5.97*
Acute depression 0.74 1.10 −1.43 – 2.91 0.74 0.92 −1.08 – 2.56
Chronic depression 0.16 1.10 −2.00 – 2.33 0.26 0.73 −1.17 – 1.70
Past depression 0.77 0.44 −0.09 – 1.64 – – –
Gender – – – −0.57 0.32 −1.21 – 0.06
Age −0.08 0.02 −0.12 – -0.04* −0.03 0.04 −0.10 – 0.04
Regulation strength 1.88 0.24 1.36 – 2.21* 1.47 0.56 0.17 – 2.19*
Acute depression −0.19 0.95 −1.67 – 1.78 6.39 6.48 −1.90 – 21.60
Chronic depression −0.10 0.97 −1.58 – 1.93 9.62 5.77 1.96 – 23.34*
Past depression 0.39 0.47 −0.42 – 1.42 – – –
Gender – – – 0.61 1.11 −1.05 – 3.13
Age 0.05 0.021 0.01 – 0.09* −0.08 0.11 −0.30 – 0.13
Variability 2.73 0.05 2.64 – 2.83* 1.37 0.24 0.90 – 1.84*
Acute depression 0.45 0.31 −0.15 – 1.05 0.14 0.49 −0.82 – 1.10
Chronic depression 0.05 0.32 −0.57 – 0.67 0.28 0.38 −0.48 – 1.04
Past depression 0.16 0.12 −0.09 – 0.40 – – –
Gender – – – −0.36 0.17 −0.70 – -0.02*
Age −0.01 0.01 −0.00 – -0.02* −0.02 0.02 −0.06 – 0.02
Note: N = 523 (female twin), N = 30 (pair-matched). Estimates for γ and β are on the log scale. Set point is corrected for time of day and time of day and time of day
squared. CI = credibility interval.
* 95 % CI does not include zero.
# Intercept for set point is at 12 a.m.
Fig. 3. Continuous time autocorrelation function for β = 1.8.
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could also be applied to experimental data (e.g. laboratory stressors),
but the recommendation of at least 50 time points still stands. In these
situations, it is worthwhile to sample several times within an hour to
separate reactivity to the stress task from fluctuations due to other
factors (e.g. ultradian rhythm).
Our hypothesis that cortisol’s regulation strength would be higher in
depressed individuals was supported in the pair-matched sample only.
It was found that depressed individuals, and in particular chronically
depressed individuals, had faster returns to the set point (and reduced
autocorrelation), while they did not credibly differ in terms of varia-
bility and set point. Although we replicated the finding of Peeters et al.
(2004) in the pair-matched sample, we did not do so in the female twin
sample. This may be in part due to different sample characteristics. The
pair-matched sample was more similar to the Peeters et al. (2004)
sample than the female twin sample, as it also recruited participants
from outpatient clinics, and preselected on a minimum level of de-
pressive symptoms (> 14 on the BDI). Also, in the pair-matched sample
there was a preselection on the non-depressed individuals; scores above
8 on the BDI were not allowed. The female twin sample was recruited
from the general population, and there was no preselection on symptom
levels. Hence, the pair-matched depressed sample may have been a
more severely depressed sample, in terms of symptomatology and/or
functioning (given that they sought help for their problems), and the
contrast between depressed and non-depressed individuals may have
been greater. Although no direct comparisons can be made, the SCL-90
depression scores (usual cut-off: 1.56, Aben et al., 2002) of the de-
pressed and non-depressed groups of the female twin sample seem to lie
closer to each other than the BDI scores of the groups in the pair-
matched sample. In combination with the general problem of the small
number of individuals in the depressed groups, this may have reduced
power to detect differences, especially in the female twin sample.
However, the exact post-hoc power is difficult to quantify with complex
multilevel stochastic differential equation models such as the current
one. Another possibility for differential results between the pair-mat-
ched and female-twin sample is a difference in the distribution of in-
dividuals with melancholic versus other types of depression; melan-
cholic depression has been associated with altered HPA axis functioning
more consistently than other types of depression (Lamers et al., 2013;
Karlović et al., 2012). Post hoc comparison of the distribution of in-
dividuals with symptoms associated with melancholic depression (hy-
posomnia and loss of appetite/weight) across both samples, showed
that the pair-matched sample included relatively many individuals with
melancholic symptoms, as compared to the female twin sample: five
individuals (33.3 %) in the pair-matched sample, and three (14.3 %) in
the female twin sample.
Thus, we found at least partial support for our hypothesis that de-
pressed individuals have altered cortisol regulation strength. To un-
derstand possible underlying mechanisms for this finding, we connect
our results to the existing literature. Another study has found lower
autocorrelation in subsequent cortisol values as well as more erratic
cortisol output. The explanation of these patterns focused on reduced
negative glucocorticoid feedback after perturbations (Peeters et al.,
2004); however, our results rather support the idea that cortisol reg-
ulation is increased. Although we agree that the overall pattern of the
salivary cortisol time series looks more erratic and spiky, the resulting
autocorrelation curve suggests that this is due to increased regulation
strength over an already short interval, possibly at the level of ultradian
oscillations. This is in line with studies in chronically stressed animals
and severely depressed men, in which the frequency of ultradian pul-
satility was increased (Deuschle et al., 1997; Young et al., 2004), and
with a study in which the duration of a cortisol burst was decreased in
depressed individuals with high cortisol levels compared to non-de-
pressed individuals (Carroll et al., 2012).
Another interesting finding was the lower set point and variability
and increased regulation with increasing age in the female twin sample.
In other studies, age has been mainly examined in terms of basal levels,
limiting our comparisons to the set point only. In some of these studies,
it has been found that cortisol levels increase with age (Nicolson et al.,
1997; Seeman et al., 2001), but in others this was found only for men
(Larsson et al., 2009), or for specific times of day (Roelfsema et al.,
2017). However, these studies mostly compared adults (30–40) to el-
derly people (60–80). The female twin sample included individuals in
the broad age range of 20–60, with a few exceptions of 60 + . One
study did look at age effects on cortisol across the day in a similarly
broad age range (Roelfsema et al., 2017). Interestingly, aggregated over
the day, they found increased cortisol levels in older individuals, but
when looking at specific times of day, they found decreased cortisol
levels in the afternoon, and increased levels in the late evening and
night, suggesting a flattening of the circadian rhythm. Hence, our
finding of decreased cortisol levels with increased age may be the result
of the timing of our assessments.
Another possible explanation for the finding of lower salivary cor-
tisol levels and variability in older (female) adults is the fact that this
study was done in ecologically valid settings, while other studies were
mostly conducted under more standardized conditions. These differ-
ences in research methods might themselves lead to differences in
findings, as has been shown in other EMA studies (e.g. Bylsma et al.,
2011). In developmental psychology, theories such as the strength and
vulnerability integration (Charles, 2010) and socioemotional selectivity
theory (Carstensen et al., 1999) postulate that healthy older adults are
more efficient at regulating their affect than younger adults, in part
because older adults limit exposure to potentially perturbing stimuli.
Evidence for this proposition has been found with EMA studies as well
(Wood et al., 2017). Wood et al. (2017) found reduced emotional
arousal and arousal variability with increasing age in a cohort of in-
dividuals in the range of 18-89. Because cortisol is sensitive to similar
kinds of perturbing stimuli as feelings of arousal (Koolhaas et al., 2011),
a similar explanation may hold for decreasing levels and variability of
cortisol in older adults.
4.1. Strengths and limitations
The results should be interpreted in the light of several strengths
and limitations. A strength of this study was the large female twin
sample and the examination of a second, slightly different replication
sample, which allowed us to draw more firm conclusions about cortisol
dynamics in daily life. A drawback was that the depressed subgroups in
both samples were rather small. Hence, we may have lacked power to
detect differences between the depressed and non-depressed subgroups.
In addition, several potential confounding variables that could also
explain individual differences in cortisol dynamics were not taken into
account. These include factors like menstrual cycle phase during the
EMA paradigm, and menopausal status.
5. Conclusion
We examined several aspects of cortisol dynamics in two samples of
depressed and non-depressed individuals, in ecologically valid settings.
Despite differences in sample size, gender, inclusion criteria, and
sampling schemes, the relative parameters were similar across samples,
indicating that cortisol dynamics can be successfully captured in daily
life with the continuous-time process model that we used. Furthermore,
we provided further evidence that individual differences in cortisol
regulation strength relates to depression. Future studies should re-
plicate these effects in larger samples, especially with more depressed
individuals and preferably with measurement burst designs (Boker
et al., 2009; Ram et al., 2014), assessing these dynamics before, during
and after a depressive episode, to better understand the nature of the
association between changing cortisol dynamics and depression. Fi-
nally, we suggest to further explore the nature of individual differences
in cortisol regulation, by including contextual moderators.
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